<DOC>
	<DOCNO>NCT02244814</DOCNO>
	<brief_summary>The rapidly rise risk gestational diabetes pregnant woman demand effective diet strategy develop due high risk fetal overgrowth , place newborn increase risk childhood obesity metabolic syndrome . The aim randomize clinical trial compare effect 8-wk isocaloric high complex carbohydrate/lower fat diet vs. conventional low carbohydrate ( high fat ) diet glycemic lipid profile , maternal insulin resistance , placenta nutrient transporter , maternal microbiome , neonatal intrahepatic fat , neonatal total adiposity ( primary outcome ) . The investigator follow infant 1-yr measure maternal breast milk infant microbiome composition observe impact net fat mass gain differently infant expose one diet vs. . Identifying diet gestational diabetes mellitus woman effectively alter maternal/fetal metabolism critical reduce short- long-term metabolic risk grow cohort mother infants potential applicable overweight/obese pregnant woman .</brief_summary>
	<brief_title>Trial Diet Gestational Diabetes Mellitus : Metabolic Consequences Mother Offspring</brief_title>
	<detailed_description>The rapidly rise incidence gestational diabetes mellitus overweight/obese pregnant woman demand effective diet strategy develop due high risk fetal overgrowth , place newborn increase risk childhood obesity metabolic syndrome . However , lack adequate control randomized clinical trial treatment gestational diabetes diet result consensus panel abandon specific diet recommendation . If effective , diet therapy potential avoid high cost medical treatment intensified fetal monitoring grow population . Although low carbohydrate diet historically advocate decrease glucose excursion meal , carbohydrate typically replace high fat show animal non-human primate data promote insulin resistance , glucose intolerance , liver fat deposition offspring . In fact , recent human data suggest high maternal triglyceride free fatty acid , variable sensitive dietary manipulation , may least important glucose contribute excess fetal growth infant adiposity . Preliminary data base R21 , show compare conventional lower-carbohydrate ( high fat ) diet , provide high complex carbohydrate ( low fat ) diet effectively blunt postprandial glucose improves fast glucose insulin 6-7 week , less adiposity newborn . The investigator global hypothesis compare 8 week low-carbohydrate/higher fat diet , high complex carbohydrate/lower fat diet blunt maternal post-prandial free fatty acid improve insulin resistance . Improved insulin sensitivity reduce fetal over-nutrition decrease substrate availability down-regulating placental nutrient transporter , thereby reduce neonatal adiposity ( primary outcome ) .This proposal build investigator R21 study , first randomize clinical trial provide meal time gestational diabetes diagnosis throughout remainder pregnancy . The aim randomize trial compare effect 8-wk isocaloric high complex carbohydrate/lower fat diet ( 60 % carbohydrate/25 % fat ) vs. conventional low-carbohydrate ( high fat ) ( 40 % carbohydrate/45 % fat ) diet maternal insulin resistance , placental nutrient transporter , neonatal fat development . Innovative approach investigator skilled multidisciplinary team include : maternal insulin resistance systemically ( oral glucose tolerance Index ) locally ( adipose tissue lipolysis ) ; intestinal microbiome ( transfer newborn ) ; neonatal intrahepatic fat ( magnetic resonance spectroscopy ) . Persistence neonatal adiposity relevant understanding obesity risk infant . As investigator pilot data suggest infant microbiome breast milk composition impact fat accrual birth , investigator follow infant 1-yr life accounting variable . Identifying diet gestational diabetes effectively alter maternal/fetal metabolism late pregnancy fetal growth accelerate critical reduce short- long-term metabolic risk grow cohort mother infant . The study result could lead paradigm shift diet therapy gestational diabetes , potential widespread application pregnancy affect obesity alone .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<criteria>Pregnant woman age 2036 yr BMI 2639 kg/m2 time diagnosis singleton pregnancy oral hypoglycemic therapy enter study diagnose Gestational diabetes accord criterion establish American College Obstetricians Gynecologists , specifically , 2 abnormal value 100g 3 hr glucose tolerance test 205 , 206 : Fasting &gt; 95 mg/dL &lt; 105 mg/dL ; 1hr &gt; 180 mg/dL ; 2 hr &gt; 155 mg/dL ; 3 hr &gt; 140 mg/dL . extreme hypertriglyceridemia overt diabetes suspect preexist diabetes ( A1Câ‰¥6.5 % , Fasting glucose &gt; 125 mg/dL , random glucose &gt; 200/mg/dL ) woman highly likely fail diet follow criterion excluded:1 ) Fasting glucose &gt; 105 mg/dL , due high likelihood fail diet require medical treatment 139 ; 2 ) Fasting triglyceride &gt; 400 mg/dL . nonEnglish speaking Smokers ( lead cause low birth weight ) Risk factor placental insufficiency ( hypertension , renal disease , thrombophilias , rheumatologic disease , preeclampsia , steroid use , history pancreatitis , infectious disease , intrauterine growth restriction ) History pancreatitis History preterm labor Taking beta blockers/glucocorticoids</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>glucose</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>dietary carbohydrate</keyword>
	<keyword>dietary fat</keyword>
	<keyword>adiposity</keyword>
	<keyword>Air displacement plethysmography</keyword>
	<keyword>Dual X-ray Absorptiometry</keyword>
	<keyword>continuous glucose monitoring</keyword>
</DOC>